The role of plant extracts in the complex therapy of diseases of the musculoskeletal system

Medicinal plants and their secondary metabolites are increasingly used in the treatment of diseases in complex therapy. Inflammation is a pathological condition that includes a wide range of diseases such as rheumatic and immune-mediated conditions, diabetes, cardiovascular diseases, etc. Three plants are presented in the review: Harpgophytum procumbens, Curcuma longa, Bosswellia serrata, whose anti-inflammatory effects have been evaluated in clinical and experimental research. The use of Harpgophytum, turmeric and boswellia shows that these phytochemicals can directly act on multiple inflammatory mechanisms and may reduce pain and slow cartilage degradation in patients with osteoarthritis. Since treating inflammation is not a onedimensional remedy, we attempted to describe a multidimensional therapeutic approach to inflammation using phytoextracts. However, further research is needed to provide more information about the effectiveness of herbal extracts, as well as their combinations, in people with inflammatory joint diseases.

1. Ravindran PN. Turmeric – the golden spice of life., Turmeric: The genus Curcuma. Taylor and Francis Group, 2006. P. 1–14.

2. Inaba K., Murata K., Naruto S., Matsuda H.Inhibitory effects of devil’s claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages. J. Nat. Med. 2010; 64 (2): 219–222.

3. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y., Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem. Pharm. Bull. (Tokyo). 1993; 41: 1640–3.

4. Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford). 2013 Aug; 52 (8): 1408–17. DOI: 10.1093/rheumatology/kes414. Epub 2013 Jan 30. PMID: 23365148.

5. Funk J.L, Oyarzo J. N., Frye J. B., Chen G., Lantz R. C., Jolad S. D., Sólyom A. M., Timmermann B. N. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J. Nat. Prod. 2006; 69: 351–355. http://doi.org/10.1021/np050327j

6. Shehzad A., Rehman G., Lee Y. S. Curcumin in inflammatory diseases. Biofactors, 2013; 39: 69–77. http://doi.org/10.1002/biof.1066

7. Lal B., Kapoor A., Agrawal P., Asthana O., Srimal R. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother. Res., 2000; 14: 443–447. http://doi.org/10.1002/1099–1573(200009)14:6<443::aid-ptr619>3.0.co;2-v

8. Crivelli B, Bari E, Perteghella S, Catenacci L, Sorrenti M, Mocchi M, Faragò S, Tripodo G, Prina-Mello A, Torre ML. Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. Eur. J. Pharm. Biopharm. 2019 Apr; 137: 37–45. DOI: 10.1016/j.ejpb.2019.02.008. Epub 2019 Feb 14. PMID: 30772432.

9. Kim L, Kim JY. Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1β via an anti-inflammatory mechanism. Food Sci Biotechnol. 2018 Sep 18; 28 (2): 547–553. DOI: 10.1007/s10068–018–0470–6. PMID: 30956867; PMCID: PMC 6431345.

10. Zhang Z., Leong D. J., Xu L., He Z., Wang A., Navati M. et al. Curcumin Slows Osteoarthritis Progression and Relieves Osteoarthritis-Associated Pain Symptoms in a post-traumatic Osteoarthritis Mouse Model. Arthritis Res. Ther. 2016; 18 (1): 128. DOI: 10.1186/s13075–016–1025-y

11. Henrotin Y., Malaise M., Wittoek R., de Vlam K., Brasseur J. P., Luyten F. P. et al. Bio-optimized Curcuma Longa Extract Is Efficient on Knee Osteoarthritis Pain: a Double-Blind Multicenter Randomized Placebo Controlled Three-Arm Study. Arthritis Res. Ther. 2019; 21 (1): 179. DOI: 10.1186/s13075–019–1960–5

12. Feng J, Li Z, Tian L, Mu P, Hu Y, Xiong F, Ma X. Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022 Oct 19; 22 (1): 276. DOI: 10.1186/s12906–022–03740–9. PMID: 36261810; PMCID: PMC 9580113.

13. Wang Z, Singh A, Jones G, Winzenberg T, Ding C, Chopra A, Das S, Danda D, Laslett L, Antony B. Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr Rheumatol Rep. 2021 Jan 28; 23 (2): 11. DOI: 10.1007/s11926–020–00975–8. PMID: 33511486

14. Zhao J., Liang G., Zhou G., Hong K, Yang W., Liu J., Zeng L. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis, Journal of Ethnopharmacology. 2024; 321: 117493. ISSN 0378–8741. https://doi.org/10.1016/j.jep.2023.117493

15. Kuptniratsaikul V., Dajpratham P., Taechaarpornkul W., Buntragulpoontawee M., Lukkanapichonchut P., Chootip C. et al. (2014). Efficacy and Safety of Curcuma Domestica Extracts Compared with Ibuprofen in Patients with Knee Osteoarthritis: a Multicenter Study. Clin. Interv. Aging 9, 451–458. DOI: 10.2147/CIA.S 58535

16. Feng J, Li Z, Tian L, Mu P, Hu Y, Xiong F, Ma X. Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022 Oct 19; 22 (1): 276. DOI: 10.1186/s12906–022–03740–9. PMID: 36261810; PMCID: PMC 9580113.

17. Wang Z, Singh A, Jones G, Winzenberg T, Ding C, Chopra A, Das S, Danda D, Laslett L, Antony B. Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr. Rheumatol. Rep. 2021 Jan 28; 23 (2): 11. DOI: 10.1007/s11926–020–00975–8. PMID: 335114861

18. Liu Y., Mi B., Lv H., Liu J., Xiong Y., Hu L. et al. (2018). Shared KEGG Pathways of Icariin-Targeted Genes and Osteoarthritis. J. Cel. Biochem.

19. Panahi Y., Rahimnia A. R., Sharafi M., Alishiri G., Saburi A. and Sahebkar A. Curcuminoid Treatment for Knee Osteoarthritis: a Randomized Double-Blind Placebo-Controlled Trial. Phytother Res. 2014; 28 (11): 1625–1631. DOI: 10.1002/ptr.5174

20. Bannuru R. R., Osani M. C., Vaysbrot E. E., Arden N. K., Bennell K., Bierma-Zeinstra S.M.A. et al. OARSI Guidelines for the Non-surgical Management of Knee, Hip, and Polyarticular Osteoarthritis. Osteoarthritis Cartilage. 2019; 27 (11): 1578–1589. DOI: 10.1016/j.joca.2019.06.011

21. Grover A. K., Samson S. E. Benefits of Antioxidant Supplements for Knee Osteoarthritis: Rationale and Reality. Nutr. J. 2016; 15: 1. DOI: 10.1186/s12937–015–0115-z

22. Senghani M. K., Patel P. M. Pharmacognostic and phytochemical study of Oleo gum resin from Boswellia serrata. Res. J. Pharmacog. Phytochem. 2013; 5: 244–250.

23. Shah B. A., Qazi G. N., Taneja S. C. Boswellic acids: a group of medicinally important compounds. Nat. Product. Rep. 2009; 26 (1): 72–89.

24. Al-Harrasi A., Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani luban). Molecules. 2008; 13 (9): 2181–2189.

25. Schauss A., Milholland R., Munson S. Indian frankincense (Boswellia serrata) gum resin extract: a review of therapeutic applications and toxicology. Nat. Med. J. 1999; 2 (2): 16–20.

26. Poeckel D., Werz O. Boswellic acids: biological actions and molecular targets. Curr. Med. Chem. 2006; 13 (28): 3359–3369.

27. Kumar A., Shah B. A., Singh S., Hamid A., Singh S. K., Sethi V. K. et al. Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs. Bioorg. Med. Chem. Lett. 2012; 22: 431–435.

28. Skarke C., Kuczka K., Tausch L., Werz O., Rossmanith T., Barrett J. S. et al. Increased bioavailability of 11-keto-betaboswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures. J. Clin. Pharmacol. 2012; 52: 1592–1600.

29. Takada Y., Ichikawa H., Badmaev V., Aggarwal B. B. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J. Immunol. 2006; 176 (5): 3127–3140.

30. Ammon H. P., Mack T., Singh G. B., Safayhi H. Inhibition of leukotriene B 4 formation in rat peritoneal neutrophiles by an ethanolic extract of gum resin exudates of Boswellia serrata. Planta. Med. 1991; 57: 203–207.

31. Gayathri B., Manjula N., Vinaykumar K. S., Lakshmi B. S., Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFα, IL-1β, NO and MAP kinases. International Immunopharmacology.2007; 7 (4): 473–482.

32. Kapil A., Moza N., Anticomplementary activity of Boswellic acids – an inhibitor of C 3-convertase of the classical complement pathway. International Journal of Immunopharmacology. 1992; 14 (7): 1139–1143.

33. Ammon H. P.T. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine.2010; 17 (11): 862–867.

34. Singh S., Khajuria A., Taneja S. C., Johri R. K., Singh J., Qazi G. N., Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine. 2008; 15 (6–7): 400–407.

35. Perera PK, Perera M, Kumarasinghe N. Effect of Sri Lankan traditional medicine and Ayurveda on Sandhigata Vata (osteoarthritis of knee joint). Ayu. 2014; 35: 411–5.

36. Shah MR, Mehta CS, Shukla VD. et al. A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis). Ayu. 2010; 31: 210–7. https://doi.org/10.4103/0974–8520.72399

37. Kimmatkar N., Thawani V., Hingorani L., Khiyani R., Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Phytomedicine. 2003; 10 (1): 3–7.

38. Etzel R. Special extract of BOSWELLIA serrata (H15) in the treatment of rheumatoid arthritis. Phytomedicine. 1996; 3 (1): 91–94.

39. Hosseini-Zare MS, Sarhadi M, Zarei M, Thilagavathi R, Selvam C. Synergistic effects of curcumin and its analogs with other bioactive compounds: a comprehensive review. Eur. J. Med. Chem. 2021; 210: 113072.

40. Jhun J, Min H-K, Na HS, Kwon JY, Ryu J, Cho K-H. et al. Combinatmarion treatment with lactobacillus acidophilus LA-1, vitamin B, and curcumin ameliorates the progression of osteoarthritis by inhibiting the pro-inflammatory mediators. Immunol Lett. 2020; 228: 112–21.

41. Vishal A. A., Mishra A., Raychaudhuri S. P. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of Aflapin® in subjects with osteoarthritis of knee. Int J. Med. Sci. 2011; 8 (7): 615–622.

42. Umar S., Umar K., Saarwar A. H., Khan A., Ahmad N. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014; 21: 847–856.

43. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Semin Arthritis Rheum. 2018 Dec;48(3):416–429. DOI: 10.1016/j.semarthrit.2018.03.001. Epub 2018 Mar 10. PMID: 29622343; PMCID: PMC 6131088.

44. Haroyan A., Mukuchyan V., Mkrtchyan N., Minasyan N., Gasparyan S., Sargsyan A., Narimanyan M, Hovhannisyan A. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern. Med. 2018; 18 (1): 7.

45. Raveendhara R. Bannuru, Mikala C. Osani, Fatimah Al-Eid, Chenchen Wang. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 2018; 48 (3): 416–429. ISSN 0049–0172. https://doi.org/10.1016/j.semarthrit.2018.03.001

46. Tapasvi S. Role of Rosehip, Devil’s claw, and Boswellia serrata in osteoarthritis: Molecular and clinical perspectives. International Journal of Orthopaedics Sciences 2023; 9 (1): 587–593.

47. Brochard S, Pontin J, Bernay B, Boumediene K, Conrozier T, Baugé C. The benefit of combining curcumin, bromelain and harpagophytum to reduce inflammation in osteoarthritic synovial cells. BMC Complement Med Ther. 2021 Oct 14; 21 (1): 261. DOI: 10.1186/s12906–021–03435–7. PMID: 34649531; PMCID: PMC 8515758

48. Chrubasik S, Zimpfer C, Schütt U, Ziegler R. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine. 1996 May; 3 (1): 1–10. DOI: 10.1016/S0944–7113(96)80003–1. PMID: 23194854

49. Nelson K. M., Dahlin J. L., Bisson J., Graham J., Pauli G. F., Walters M. A. The Essential Medicinal Chemistry of Curcumin. Journal of Medicinal Chemistry. 2017; 60 (5): 1620–1637.

50. Taghipour Y. D., Hajialyani M., Naseri R., Hesari M., Mohammadi P., Stefanucci A. et al. Nanoformulations of natural products for management of metabolic syndrome. International Journal of Nanomedicine. 2019; 14: 5303–5321.

51. Mimica B., Bučević Popović V., Banjari I., Jeličić Kadić A., Puljak L. (2022) Methods Used for Enhancing the Bioavailability of Oral Curcumin in Randomized Controlled Trials: A Meta-Research Study. Pharmaceuticals (Basel, Switzerland) 15(8).

52. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64 (04): 353–356.

53. Anand P., Kunnumakkara A. B., Newman R. A., Aggarwal B. B. Bioavailability of Curcumin: Problems and Promises. Mol. Pharm. 2007; 4 (6): 807–818. DOI: 10.1021/mp700113r

54. Abdel-Tawab M., Werz O., Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin. Pharmacokinet. 2011; 50: 349–369.

55. Bagul P., Khomane K. S., Bansal A. K. Investigating permeability related hurdles in oral delivery of 11-keto-beta-boswellic acid. Int J. Pharm. 2014; 464: 104–110.

56. Husch J., Gerbeth K., Fricker G., Setzer C., Zirkel J., Rebmann H. et al. Effect of phospholipid-based formulation of Boswellic serrata extract on the solubility, permeability and absorption of the individual boswellic acid constituents present. J. Nat. Prod. 2012; 75 (10): 1675–1682.

57. Khayyal Mohamed T., Tawab Mona, Behnam Dariush, El-Sabbagh Walaa A., El-Hazek Rania M. A new solubilized formulation of Куркуминcumin, Boswellia and Xanthohumol extract markedly enhances anti-inflammatory activity. Poster presentation, San Francisco, 2017.

58. Khayyal M. T., El-Hazek R. M., El-Sabbagh W. A., Frank J., Behnam D., Abdel-Tawab M. Micellar solubilisation enhances the antiinflammatory activities of curcumin and boswellic acids in rats with adjuvant-induced arthritis. Nutrition. 2018; 54: 189–196. ISSN 0899–9007. https://doi.org/10.1016/j.nut.2018.03.055

59. Cuomo J., Appendino G., Dern A. S., Schneider E., McKinnon T.P., Brown M. J. et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J. Nat. Prod. 2011; 74 (4): 664–669.

60. Marczylo T.H, Verschoyle R. D., Cooke D. N., Morazzoni P., Steward W. P., Gescher A. J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007; 60 (2): 171–177.

61. Sharma A., Gupta N. K., Dixit V. K. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv. 2010; 17 (8): 587–595.

62. Hüsch J., Bohnet J., Fricker G., Skarke C., Artaria C., Appendino G., Schubert-Zsilavecz M., Abdel-Tawab M. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extract. Fitoterapia. 2013; 84: 89–98. http://doi.org/10.1016/j.fitote.2012.10.002

63. Beta-sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells / Loizou S., Lekakis I., Chrousos G. P., Moutsatsou P. Mol. Nutr. Food Res. 2010; 54: 551–558.

64. Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships / Dugas A. J. Jr., Castaneda A. J., Bonin G. C. et al. J. Nat. Prod. 2000; 63: 327–331.